KOL Relationship Management in Pharma & Devices - Workshop HighlightsAnup Soans
Inside this Issue:
1. Sales Managers: Avoiding Irrelevance in Joint Field Work by K. Hariram
How to ensure that joint field work adds real value to the MR’s daily routine
2. Social Network Analysis for KOL Discovery by Salil Kallianpur
Identifying KOLs through their influence on the social network they are a part of
3. The Art and Science of KOL Management by Dr. Viraj Suvarna
Deep-dive into the art and science of identifying, selecting and engaging KOLs
4. A CEO’s perspective on KOL Management by K. Hariram
Identifying KOLs based on long-term strategy, not short term goals
5. Special Feature: How to Train Your Reps by Prof. Vivek Hattangadi
Applying Cognitive Load Theory to make training effective for your medical reps
6. No Admission! by Rakesh Tiwari
Why Reps are increasingly finding it difficult to get a foothold in the Doctor’s clinic
7. Snippets from a Pharma Field Force Veteran by Anirudha Sengupta
A veteran shares his experiences and insights on pharma sales
8. Uncertainties in Pharmaceutical Distribution Channel with Reference to Availability of New Products
Hospital marketing -Multi specilality hospital By Dr Kavita Soni Dr.Kavita Soni
Hospital Marketing has been viewed from a different perspective these days.It has become a major tool for business development in health care sector.The only challenge to incorporate and customize the core marketing concept to go well with hospital setting
KOL Relationship Management in Pharma & Devices - Workshop HighlightsAnup Soans
Inside this Issue:
1. Sales Managers: Avoiding Irrelevance in Joint Field Work by K. Hariram
How to ensure that joint field work adds real value to the MR’s daily routine
2. Social Network Analysis for KOL Discovery by Salil Kallianpur
Identifying KOLs through their influence on the social network they are a part of
3. The Art and Science of KOL Management by Dr. Viraj Suvarna
Deep-dive into the art and science of identifying, selecting and engaging KOLs
4. A CEO’s perspective on KOL Management by K. Hariram
Identifying KOLs based on long-term strategy, not short term goals
5. Special Feature: How to Train Your Reps by Prof. Vivek Hattangadi
Applying Cognitive Load Theory to make training effective for your medical reps
6. No Admission! by Rakesh Tiwari
Why Reps are increasingly finding it difficult to get a foothold in the Doctor’s clinic
7. Snippets from a Pharma Field Force Veteran by Anirudha Sengupta
A veteran shares his experiences and insights on pharma sales
8. Uncertainties in Pharmaceutical Distribution Channel with Reference to Availability of New Products
Hospital marketing -Multi specilality hospital By Dr Kavita Soni Dr.Kavita Soni
Hospital Marketing has been viewed from a different perspective these days.It has become a major tool for business development in health care sector.The only challenge to incorporate and customize the core marketing concept to go well with hospital setting
The global patient engagement solutions market size stood at around USD 11.8 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The market for patient engagement solutions is mainly driven by the increasing utilization of electronic health records for patient-centric care and the adoption of mobile health devices. According to a survey conducted by the NHS in 2019, approximately 92.0% of patients feel assured in self-managing treatment.
Market Drivers
Factors such as the growing burden of chronic diseases and a rise in the geriatric population have led to the adoption of patient engagement solutions worldwide. For instance, in 2017, according to CDC statistics, 1.3 million new cases of diabetes were recorded in the US alone. In response to the growing number of diabetic patients, companies are focusing on the development of patient-centric engagement solutions. For example, in June 2019, Allina Health launched a patient-centric engagement solution platform for improving the Diabetes Self-Management Education (DSME) program. This enables diabetic self-care clinical services, particularly for those located in remote locations. Moreover, programs such as these help in cost evaluation, operational effectiveness, and clinical outcomes.
Government support is expected to drive the adoption of patient engagement solutions in the coming years. For instance, in 2018, the FDA established the Patient and Caregiver Connection program. The program was aimed to foster engagement with patients, patient advocates, and caregivers throughout the evaluation and surveillance of medical devices.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
A program that combines the study of basic and pharmaceutical sciences with marketing and management studies; and that prepares individuals for careers in pharmaceutical sales, marketing, management, and related fields within the health care industry.
Presentation of the "Smart Field Force Framework" which has been developed to help pharma companies design the best organizational model to support the right strategy and tactics
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
A short window of opportunity exists for pharmaceutical companies to establish indispensable beyond the pill services, which may even help them 'own' particular disease areas.
The global patient engagement solutions market size stood at around USD 11.8 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The market for patient engagement solutions is mainly driven by the increasing utilization of electronic health records for patient-centric care and the adoption of mobile health devices. According to a survey conducted by the NHS in 2019, approximately 92.0% of patients feel assured in self-managing treatment.
Market Drivers
Factors such as the growing burden of chronic diseases and a rise in the geriatric population have led to the adoption of patient engagement solutions worldwide. For instance, in 2017, according to CDC statistics, 1.3 million new cases of diabetes were recorded in the US alone. In response to the growing number of diabetic patients, companies are focusing on the development of patient-centric engagement solutions. For example, in June 2019, Allina Health launched a patient-centric engagement solution platform for improving the Diabetes Self-Management Education (DSME) program. This enables diabetic self-care clinical services, particularly for those located in remote locations. Moreover, programs such as these help in cost evaluation, operational effectiveness, and clinical outcomes.
Government support is expected to drive the adoption of patient engagement solutions in the coming years. For instance, in 2018, the FDA established the Patient and Caregiver Connection program. The program was aimed to foster engagement with patients, patient advocates, and caregivers throughout the evaluation and surveillance of medical devices.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
A program that combines the study of basic and pharmaceutical sciences with marketing and management studies; and that prepares individuals for careers in pharmaceutical sales, marketing, management, and related fields within the health care industry.
Presentation of the "Smart Field Force Framework" which has been developed to help pharma companies design the best organizational model to support the right strategy and tactics
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
A short window of opportunity exists for pharmaceutical companies to establish indispensable beyond the pill services, which may even help them 'own' particular disease areas.
Overview of aspects of pharma's value added services and its primary aspects to deliver them.
Learn what others do and reflect how it's an opportunity for your pharma company..
Beyond-the-pill: how to move from selling pills to value-added solutionsexecutiveinsight
New shores: The shift from selling pills to developing value-added services has only just begun!
Biopharma companies are discovering that compelling and aligned services underpinned by a core strategy are providing them with distinctive competitive advantages.
Redefining the role of patient support programs: Shifting the focus towards p...SKIM
Presented by:
Alex Zhu, Manager
Ariel Herrlich, Analyst
The recent shift toward consumerism and patient empowerment is driving companies to reevaluate the role and design of patient support programs. Historically, pharmaceutical manufacturers implemented support programs largely as a way to address patient non-adherence.
These programs were often single-based solutions designed to meet mass market needs. Next generation patient support programs will go beyond simple adherence to address holistic disease management through individualized, patient-centric service offerings.
Using a case study, we illustrated:
- How to evaluate your current patient support program offerings, using a combination of standard and non-standard metrics and exercises
- Re-define what “value” means in a world of patient-centricity and personalized care
- Assess the impact/ROI of potential new service offerings and enhancements
The new pharma, customer centric, databased business modelA.R.J. (Rob) Halkes
Customer focus is the core and the basis for all commercial activities for pharma. Customers, physicians and patients expect effective therapies in drugs and support. Sustainable relations with customers are necessary to build trusted relations to create a cooperation to realize that. This tells you how to!
Creating value through patient support programsSKIM
How do we become more patient-centered as an organization? How do we ensure the patient/caregiver experience is as optimal as possible?
These are the questions that are being poised to healthcare market researchers in today’s healthcare landscape. And typically healthcare market researchers are turning to methods like “patient journeys” and “patient personas” to help bring that patient-centered understanding to the organization. Problem is … in order to be truly patient-centered, you need to take this charge on from the inside out.
Experience, Design and Innovation departments are springing up in all kinds of healthcare organizations intent on facilitating the organizational shift towards patient-centricity. And, unfortunately, market researchers are intentionally not being invited to the table. If history repeats itself, that will soon change though. These Experience, Design and Innovation departments will need the rigor and breadth of method knowledge that market researchers have in order to succeed in the strategic agendas of their work.
This presentation will give market researcher pointers on which skills, methods and mindsets they’ll likely need to adopt if they are hoping to be perceived as a valued contributor to an Experience, Design or Innovation team. In essence, give attendees a blueprint for how to open up a whole new professional opportunity for themselves, with a simple reframe on whom they are and what they do.
Digital Health Funding 2014 Midyear Report by @Rock_HealthRock Health
A summary of the companies, investors and themes that drove digital health funding to a record $2.3B only halfway through 2014, exceeding the entire 2013 total. Includes details on crowdfunding, exits, and digital health in the public markets, encompassing our new index of publicly-traded digital health companies. Purchase this report here: https://gumroad.com/l/WURST
Updated on July 21, 2014 to reflect final Q2 data on venture funding and deals.
Analysis of what patient services proposed by pharma companies should be. This document explains: 1. why patient centricity is essential? - 2. how to craft a patient-centric strategy? - 3. How to implement patient-centric initiatives?
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...No Fixed Address Health
Learn about the shifting landscape within healthcare decision-making and how the traditional model has evolved into a more collaborative approach. Discover three drivers within the life science marketing landscape accelerating this shift and what this all means to Pharma Brand Marketers. What's at stake for a brand failing to address these shifts?
Avident Health created by doctors to allow better teamwork in healthcare and to engage and educate patients. More teamwork leads to value: Better quality at lower cost.
The Complete Guide to Wellness Software DevelopmentMentorMate
Healthcare. It’s just one word, but it feels like over a hundred problems and potential solutions spun up like a spider web — benefits, cost savings and improvements are stuck together without being truly connected.
When developing a business strategy centered on the patient, organizations must adapt and implement programs that foster information sharing and collaboration while providing faster and greater access to life-changing products.
Tap into our integrated system. See how your organization can achieve a new level of care and financial success. Leverage the NextGen Healthcare Ambulatory Ecosystem for your healthcare IT needs.
Market Access for Specialty Products in Latin Americaexecutiveinsight
Executive Insight examines the market access challenges and opportunities specifically for premium, specialty inpatient products in the Latin American (LatAm) region
Market Access - Getting ready for Personalized Medicine!executiveinsight
A presentation outlining the potential gains, pitfalls and strategies needed to realize the value in Personalized Medicine (Companion Diagnostics, Therapies).
Market Access - Getting ready for Personalized Medicine!executiveinsight
A presentation outlining the potential gains, pitfalls and strategies needed to realize the value in Personalized Medicine (Companion Diagnostics, Therapies).
Many pharmaceutical companies still prefer to deal with their stakeholders one-by-one in a controlled way. They are often at their most comfortable dealing with clinical opinion leaders, talking about the benefits of their products. But are they missing a trick?
10 essential questions for successful kol managementexecutiveinsight
Here we present 10 questions to ask yourself when planning your KOL management strategy. In questions one to five, we first ask who you should reach out to and what to aim for with a KOL management programme. In the following questions we will examine how you can optimise the working relationship in a way that benefits all parties involved.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Creating value beyond the pill
1. How to Create and Capture
Value Beyond the Pill
“Big Pharma has to move beyond just „selling the pill„ ”
Joseph Jimenez, Novartis CEO
2. Beyond-the-pill is a logical and inevitable
path forward for all
PAYERS
Rising costs of chronic
disease management –
focus on outcome vs
cost
UNMET NEEDS
Opportunities for improved care
NEW TECHNOLOGIES
New service possibilities
PHARMAS
Increasingly difficult to
differentiate through
pills alone
PATIENTS
Demanding more
support on managing
chronic conditions
Creating value by embedding products into a holistic
offering with the aim to improve patient outcomes and
provide tangible competitive advantages
Executive Insight AG 2
3. Leading pharma companies have started to experiment
with services beyond-the-pill
Executive Insight AG 3
Innovative solutions that
facilitate shared decision
making between patients and
physicians
„Proteus ingestible sensor for
tracking medication intake
receives FDA clearance“
Integrated care model for
schizophrenia patients in
Germany
In-house Care Mgt. Subsidiaries:
Partnerships & Alliances: Healthcare Stakeholder Collaborations:
Patient Support Programs:
&
For example:
4. Done right, significant impacts can be achieved with
services beyond the pill
Executive Insight AG 4
Better Health Outcomes
In outpatient settings, patient assistance program enrolment plus
additional medication services (e.g., counseling, reminders) is
associated with improved disease indicators for patients.
(Tisha Moniek Felder, Jan. 2010,
http://digitalcommons.library.tmc.edu/dissertations/AAI3398971)
Easier Access to Therapy
Especially for newly launched products with delays in coverage
decisions by PBMs, health plans and government payers.
(Suzanne Shelley, Pharmaceutical Commerce, February 26, 2013)
Increased Brand Loyalty
Through the “Lipitor For You” program Pfizer
maintained three times the normal market share
for Lipitor after the first generic hit.
(http://beyondthepill.medivo.com/2012/08/coupons-and-
co-pays-how-a-few-brands-are-battling-generics/)
5. 5
Adding standard off-the-shelf services to a product
is the fast & easy tactical approach
Executive Insight AG
Patient website...
An app... A reminder...
A brochure ...
6. But these services are often disconnected and
fail to truly address stakeholder needs
Executive Insight AG 6
Awareness
Diagnosis
Monitoring
Fear & anxietyPoor physician-patient
communication
Diagnostics not part
of all check-ups or
not reimbursed
Can a simple brochure deal
with emotional & inter-
personal challenges?
Early symptoms
not recognized
Is an awareness
campaign sufficient?
Therapy
Challenges along a patient‘s journey
Complex
medication for
co-morbid
patients
Side effects and drug-
drug interactions
Is a simple product
information enough?
Can a reminder address
intentional non-adherence?
Intentional & non-
intentional non-
adherence
Social withdrawal,
avoidance, isolation
What about the patient‘s
overall well-being?
7. Our beyond-the-pill excellence method
ensures a strategic approach
Executive Insight AG 7
Diagnose Define Design Implement
Nature of disease: e.g. no
symptoms / difficult
diagnosis etc.?
Stakeholders: Needs
along the patient journey?
Competition: Minimum
services required to match
offerings?
Brand: Specific
requirement e.g. injection
or first dose monitoring?
Goal of the overall service
strategy?
Fit with product portfolio?
Key components (breadth
& depth of offerings) of
service strategy?
How success is to be
measured?
Priority steps & needs to
be addressed with
services?
How to co-create services
with customers to ensure
relevance and
acceptance?
How to include internal
cross-functional
knowledge and input?
Priority steps & needs to
be addressed with
services?
How to co-create services
with customers to ensure
relevance and
acceptance?
How to include internal
cross-functional
knowledge and input?
What factors drive
the service model?
Which service
strategy?
What services
to offer?
How to implement
the services?
8. Diagnose: Full understanding of disease, competition
and stakeholder landscape service implications
Executive Insight AG 8
Example of Structured Analyis:
Competition Baseline to match services currently
offered by competitors? Areas of differentiation?
Disease & Brand Nature of the disease &
implication on service? Product fit with the current
disease and therapy settings? Any product features
presenting a need or an opportunity for service
offerings (eg. injection, first dose monitoring)?
Stakeholders Physical, emotional & financial
journey of patient – unmet needs & decision points?
Diagnostic
To understand the implications of the disease,
brand, competition and stakeholder needs for the
service model strategy.
9. Define: A strategy and service model that best fits you
Executive Insight AG 9
Limited Offering
Generic services targeting one or
few steps in the patient pathway
(e.g. benefits investigation)
LevelofCustomization
Low
High
Breadth of OfferingFew Many
Focused Offering
Highly customized services targeting
one or few steps in the patient
pathway (e.g. emergency on-site
diagnosis for acute indications)
Broad Offering
Bundle of generic services targeting
most steps of the patient pathway
(e.g. blockbuster offering for primary
care indication)
Relationship Offering
Complete solutions that are highly
customized and cover the entire
patient pathway (e.g. complex chronic
specialty indications)
Executive Insight Service Models:
10. Design: Services that are truly relevant with ownership
and commitment from your customers
Executive Insight AG 10
Collaborate with
stakeholders
along patient journey to fully
understand needs and opportunities
Executive Insight‘s inclusive and collaborative
Deep Dive Methodology
Co-create innovative
solutions with you
by harnessing collective
imaginative power
Process OptimizationDiagnosis Education/Training
Adherence / ComplianceLifestyle/Peer-to-Peer
MonitoringTreatment DecisionAwareness
Access
Tpyes of services created e.g.:
11. Winning
Beyond-the-Pill
Service Strategy
Implement: Driven towards meeting key success factors
Executive Insight AG 11
Take a needs-based
approach
Patient/stakeholder’s (not the
brand) perspective to address
needs along the patient journey
Consider ALL
stakeholder groups
Other key players beyond
HCP & patients e.g. care-
givers, pharmacists
Co-develop solutions
with customers
Higher relevance and adoption
of service solutions
Clarify ownership &
resourcing
Allocation of funding and
resources pre-launch as well
as early affiliate involvement
Start early
Sufficient lead time for piloting &
implementation with roadmap of
comprehensive service solution
well before launch
Leverage external
partners
Multiple areas of expertise and
multi-country execution
12. Our experience is already helping to shape
beyond-the-pill thinking in the market
Executive Insight AG 12
Thought-leading publications: Founders of the beyond-the-pill
group on LinkedIn:
http://www.executiveinsight.ch/publications http://www.linkedin.com/groups?gid=4383768&trk=myg_ugrp_ovr
Track record:
Beyond-the-pill projects with
leading global pharma companies
13. Call us to discuss how you can also develop &
implement a winning beyond-the-pill strategy
Company address
Contacts
Meike Wenzel
Mobile: +41 79 322 12 39
m.wenzel@executiveinsight.ch
Executive Insight AG
Metallstrasse 9
CH-6304 Zug
Tel. +41 (0)41 710 71 63
www.executiveinsight.ch
info@executiveinsight.ch
Marc Pesse
Mobile: +41 78 639 52 43
m.pesse@executiveinsight.ch
Executive Insight AG 13